The San Diego biotech made an unsolicited bid to buy Evotec for 2 billion euros. Elsewhere, Bluebird recorded its first ...

Completed pre-BLA meeting with FDA with full alignment on content of BLA, including CMC module, and path for fourth quarter 2024 rolling BLA submission for PRGN-2012† ...

Gene therapy involves the introduction of new genes into cells, to restore or add gene expression, for the purpose of treating disease. Most commonly a mutated gene is replaced with DNA encoding a ...

has expanded its reach by acquiring a 50% equity interest in MSO Metro, LLC, enhancing their management of 50 outpatient physical therapy clinics, mainly in New York. This strategic acquisition ...

If you’re a teen wondering if you can get online therapy and if it will work for you, read on to learn more about it and see which services pass our criteria. Why Talkspace is best overall ...

New strategic partnership leverages the power of the Dyno platform ... and commercialization activities for multiple neurological gene therapy product candidates leveraging novel Dyno capsids. Roche ...

Summary. Being told you’re not strategic enough can be frustrating. If your strategy isn’t seen and understood, it’s as if it doesn’t exist at all. By making your strategy visible and easy ...

The Acting Minister of Foreign Affairs in the Government of National Unity (GNU), Taher Al-Baour, has discussed strengthening the strategic partnership with the United Nations Development Programme ...

As a platform built to solve the most critical challenges facing gene therapy developers, Dyno’s industry-leading gene delivery solutions enable Dyno partners to create ever better gene therapies.

New strategic partnership leverages the power ... and commercialization activities for multiple neurological gene therapy product candidates leveraging novel Dyno capsids. Roche will pay Dyno ...

Intellia Therapeutics on Thursday released detailed Phase 2 results from a study of a gene-editing therapy for hereditary angioedema, drawing mixed reactions from investors and experts. The therapy, ...